Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol.

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1654169

This article is part of the Research TopicFormation of Immunological Niches in Tumor Microenvironments: Mechanisms and Therapeutic PotentialView all 31 articles

Correction: Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment

Provisionally accepted
  • 1Qinghai University Medical College, Xining, China
  • 2Qinghai Provincial People's Hospital, Xining, China
  • 3Qinghai University State Key Laboratory of Plateau Ecology and Agriculture, Xining, China
  • 4Research Center for High Altitude Medicine, Qinghai University, Xining, Qinghai, China
  • 5Key Laboratory of the Ministry of High Altitude Medicine, Qinghai University, Xining, Qinghai, China

The final, formatted version of the article will be published soon.

Frontiers' correction template for authors A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval. Instructions: ●Please read through all the templates before choosing ●Pick the most relevant text template(s) from the following page and delete all others. ●Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. ●Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary ●Submit to Frontiers following the instructions on this page. When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example: There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake. The original version of this article has been updated. In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Correction: Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment Correction on: Wang T, Lei Y, Sun J, Wang L, Lin Y, Wu Z, Zhang S, Cao C and Wang H (2025) Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment. Front. Oncol. 14:1536406. doi: 10.3389/fonc.2024.1536406 Error in figure/table Wrong content There was a mistake in figure 1B as published. The figure contains an error caused by an unintentional assembly mistake: while adjusting the layout to keep the spacing and formatting uniform, we duplicated a placeholder image that inadvertently overwrote the correct panel, resulting in incorrect image usage. The corrected figure 1 appears below. The original version of this article has been updated. Error in figure/table There was a mistake in figure 4B as published. The figure contains an error due to an unintentional mistake during assembly, where the "4T1-Invasion-Dig" image was overwritten by the "MDA-MB-231-Invasion-AA" image, resulting in incorrect image usage. The corrected figure 4 appears below. The original version of this article has been updated. Reminder: Figures, tables, and images will be published under a Creative Commons CC-BY license and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, to follow any citation instructions requested by third-party rights holders, and cover any supplementary charges.

Keywords: Immune checkpoint blockade, Triple-negative breast cancer, Malignant phenotype, nanos1, PD-1 inhibitors, Tumor microenvironments

Received: 26 Jun 2025; Accepted: 19 Aug 2025.

Copyright: © 2025 Wang, Lei, Sun, Wang, Yuxin, Wu, Zhang, Cao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Haiyan Wang, Qinghai University Medical College, Xining, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.